Drug-Drug Interaction Study of Colchicine and Theophylline

Completed · Phase 1

Conditions studied: Pharmacokinetics

In brief

Colchicine is a supressor of hepatic CYP1A2 and theophylline is a sensitive CYP1A2 probe substrate. When the two are co-administered the potential exists for a clinically significant drug interaction. This study aims to determine the effect of steady-state colchicine on the pharmacokinetics of theophylline administered as a single dose. A secondary goal is to evaluate the safety and tolerability of this regimen in healthy volunteers. All study subjects will be monitored for adverse events throughout the entire study period.

Key facts

Study ID
NCT00983905
Run by
Mutual Pharmaceutical Company, Inc.
People needed
30
Starts
2008-08-01
Expected to finish
2008-09-01
Last updated by the study team
2010-03-02

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.